UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of ketanserin, a new blocking agent of the 5‐HT2 receptor, on airway responsiveness in asthma

Allergy (Copenhagen), 1990-02, Vol.45 (2), p.151-153

1990

Volltextzugriff (PDF)

Acute respiratory and cardiovascular effects of inhaled ketanserin in chronic obstructive pulmonary disease. A comparative study with intravenously administered ketanserin

Chest, 1990-04, Vol.97 (4), p.901-905

1990

Volltextzugriff (PDF)

Ketanserin alone and in combination with enalapril in the treatment of essential hypertension: assessment of the haemodynamic effects

Journal of international medical research, 1993-05, Vol.21 (3), p.113-125

1993

Volltextzugriff (PDF)

Clinical experience with ketanserin in the treatment of hypertension

Journal of hypertension. Supplement, 1986-04, Vol.4 (1), p.S81-S83

1986

Volltextzugriff (PDF)

Ketanserin, a new blocking agent of serotonin S2-receptors. Respiratory functional effects in chronic obstruction of the airways

Chest, 1987-11, Vol.92 (5), p.863-866

1987

Volltextzugriff (PDF)

Platelet Activation Indices in Short-Term Ketanserin Treatment

Journal of cardiovascular pharmacology, 1987-09, Vol.10 (3), p.369-369

1987

Volltextzugriff (PDF)

Raynaud's disease: a new therapeutic approach with a 5-HT2 receptors blocker

Bollettino chimico farmaceutico, 1985-10, Vol.124 (10), p.121S

1985

Volltextzugriff (PDF)

Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients

International journal of clinical pharmacology research, 1988, Vol.8 (5), p.321

1988

Volltextzugriff (PDF)

Ketanserin hypertension and chronic alcoholism DB study in 40 patients

Bollettino chimico farmaceutico, 1985-10, Vol.124 (10), p.125S

1985

Volltextzugriff (PDF)

Flunarizine, cerebral blood flow and reversion of experimental atherosclerosis in rabbit

Drugs under experimental and clinical research, 1985, Vol.11 (12), p.845

1985

Volltextzugriff (PDF)

Effect of ketanserin, a new blocking agent of the 5‐HT 2 receptor, on airway responsiveness in asthma

Allergy (Copenhagen), 1990-02, Vol.45 (2), p.151-153

1990

Volltextzugriff (PDF)

Effect of ketanserin, a new blocking agent of the 5-HT sub(2) receptor, on airway responsiveness in asthma

Allergy (Copenhagen), 1990-01, Vol.45 (2), p.151-153

1990

Volltextzugriff (PDF)

Ridogrel, a new platelet antiaggregant molecule with a double mechanism of action. A pharmacological and clinical profile

Recenti progressi in medicina, 1991-10, Vol.82 (10), p.533

1991

Volltextzugriff (PDF)

Ketanserin and captopril interaction in the treatment of essential hypertensives

Cardiovascular drugs and therapy, 1990, Vol.4 (1), p.119-122

1990

Volltextzugriff (PDF)

Comparison of ketanserin and enalapril in the treatment of mild-to-moderate essential hypertension

Cardiovascular drugs and therapy, 1990, Vol.4 (1), p.123-126

1990

Volltextzugriff (PDF)

Effect of the selective 5-HT sub(2) antagonist ketanserin on adenosine-induced bronchoconstriction in asthmatic subjects

Immunopharmacology, 1992-01, Vol.23 (1), p.21-28

1992

Volltextzugriff (PDF)

Effect of the selective 5-HT2 antagonist ketanserin on adenosine-induced bronchoconstriction in asthmatic subjects

Immunopharmacology, 1992, Vol.23 (1), p.21-28

1992

Volltextzugriff (PDF)

Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity

Molecular psychiatry, 2014-10, Vol.19 (10), p.1143-1149

2014

Volltextzugriff (PDF)

Ketanserin in association with a beta blocker and a diuretic in the treatment of essential hypertension

Bollettino chimico farmaceutico, 1985-10, Vol.124 (10), p.117S

1985

Volltextzugriff (PDF)

Transfusion of granulocytes

Clinica terapeutica, 1981-01, Vol.96 (2), p.201

1981

Volltextzugriff (PDF)

Case of hypogammaglobulinemia: clinical and immunological study, and possibilities of therapy

Clinica terapeutica, 1980-12, Vol.95 (5), p.565

1980

Volltextzugriff (PDF)

Current diagnostic and therapeutic trends in obliterating arteriopathies: oscillometry and Doppler examination

Clinica terapeutica, 1980-10, Vol.95 (2), p.115

1980

Volltextzugriff (PDF)

Milk thistle (Silybum marianum) derivatives in the therapy of chronic hepatopathies

Clinica terapeutica, 1980-08, Vol.94 (3), p.283

1980

Volltextzugriff (PDF)

Hippocampal abnormalities and memory deficits in Parkinson disease: a multimodal imaging study

Neurology, 2012-06, Vol.78 (24), p.1939-1945

2012

Volltextzugriff (PDF)

Association of Choroid Plexus Volume With Serum Biomarkers, Clinical Features, and Disease Severity in Patients With Frontotemporal Lobar Degeneration Spectrum

Neurology, 2023-09, Vol.101 (12), p.e1218

2023

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(52)

Sprache

Englisch
(45)
Italienisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of ketanserin, a new blocking agent of the 5‐HT2 receptor, on airway responsiveness in asthma

Acute respiratory and cardiovascular effects of inhaled ketanserin in chronic obstructive pulmonary disease. A comparative study with intravenously administered ketanserin

Ketanserin alone and in combination with enalapril in the treatment of essential hypertension: assessment of the haemodynamic effects

Clinical experience with ketanserin in the treatment of hypertension

Ketanserin, a new blocking agent of serotonin S2-receptors. Respiratory functional effects in chronic obstruction of the airways

Platelet Activation Indices in Short-Term Ketanserin Treatment

Raynaud's disease: a new therapeutic approach with a 5-HT2 receptors blocker

Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients

Ketanserin hypertension and chronic alcoholism DB study in 40 patients

Flunarizine, cerebral blood flow and reversion of experimental atherosclerosis in rabbit

Effect of ketanserin, a new blocking agent of the 5‐HT 2 receptor, on airway responsiveness in asthma

Effect of ketanserin, a new blocking agent of the 5-HT sub(2) receptor, on airway responsiveness in asthma

Ridogrel, a new platelet antiaggregant molecule with a double mechanism of action. A pharmacological and clinical profile

Ketanserin and captopril interaction in the treatment of essential hypertensives

Comparison of ketanserin and enalapril in the treatment of mild-to-moderate essential hypertension

Effect of the selective 5-HT sub(2) antagonist ketanserin on adenosine-induced bronchoconstriction in asthmatic subjects

Effect of the selective 5-HT2 antagonist ketanserin on adenosine-induced bronchoconstriction in asthmatic subjects

Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity

Ketanserin in association with a beta blocker and a diuretic in the treatment of essential hypertension

Transfusion of granulocytes

Case of hypogammaglobulinemia: clinical and immunological study, and possibilities of therapy

Current diagnostic and therapeutic trends in obliterating arteriopathies: oscillometry and Doppler examination

Milk thistle (Silybum marianum) derivatives in the therapy of chronic hepatopathies

Hippocampal abnormalities and memory deficits in Parkinson disease: a multimodal imaging study

Association of Choroid Plexus Volume With Serum Biomarkers, Clinical Features, and Disease Severity in Patients With Frontotemporal Lobar Degeneration Spectrum

Suchergebnisse filtern